The biopharmaceutical industry challenges are to: increase speed; improve flexibility; and reduce the cost to supply a drug or therapy, Biopharm Services has supported the BioPhorum Operations Group (BPOG) by modelling manufacturing options to identify the cost drivers and potential of technology options to meet these challenges. BPOG and Biopharm Services want to give access to the models and assumptions that were used to generate the results shown in the report: The Technology Roadmap for the Biopharmaceutical Manufacturing Industry.
The BPOG, a cross-industry collaboration, has published the first edition of The Technology Roadmap for the Biopharmaceutical Manufacturing Industry. By participating in a dynamic technology management process, member organisations are building close technical partnerships, improving the risk-reward profile for new technology development and enabling faster adoption of new technologies.
The Manufacturing Technology Roadmap Tool requires Excel 2013, 2016 file users can:
• View detailed outputs for baseline scenarios
• Interrogate and compare the options
• Access a set of benchmark baseline processes that represent an industry consensus for the first time
Quantitative computational models provide valuable insight in estimating the value of a technology or process innovation that would otherwise be difficult to predict: the BioSolve analysis tool was used to model the biopharmaceutical manufacturing scenarios. A consensus was agreed for the current state of the manufacturing for the following scenarios (baseline):
1. Large Scale Stainless Steel Fed Batch
2. Intermediate‐scale Single‐Use Perfusion
For those individuals and organisations that don’t use BioSolve we are making a database of results and key assumptions available as a Manufacturing Technology Roadmap Tool. For those that have access to the BioSolve Process modelling platform the actual models will be made available as downloads from BioSolve Central. As they become available we will notify you via our regular monthly newsletter.
Future work will focus examining the 5 year and 10 year views for these scenarios and will expand to cover additional scenarios.
Click here if you would like to know more about BioSolve Process.